A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment
Condition: Hepatitis C, Chronic Interventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin Sponsor: Hoffmann-La Roche Completed - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2016 Category: Research Source Type: clinical trials